Detalhe da pesquisa
1.
Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.
J Infect Dis
; 209 Suppl 1: S28-31, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24626869
2.
Pertussis pathogenesis--what we know and what we don't know.
J Infect Dis
; 209(7): 982-5, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24626533
3.
Visualization of immune pathways that enhance the neutralizing antibody response to vaccines after primary immunization.
mBio
; 15(3): e0003724, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334423
4.
Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenicity of Bacillus anthracis protective antigen.
Infect Immun
; 81(1): 278-84, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23115046
5.
Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
Vaccine
; 40(32): 4318-4321, 2022 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710508
6.
Secretion of Pertussis Toxin from Bordetella pertussis.
Toxins (Basel)
; 13(8)2021 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34437445
7.
Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.
J Infect Dis
; 209 Suppl 1: S32-5, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24626870
8.
Stabilization of the pertussis toxin secretion apparatus by the C terminus of PtlD.
J Bacteriol
; 190(21): 7285-90, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18723610
9.
Improving the stability of recombinant anthrax protective antigen vaccine.
Vaccine
; 36(43): 6379-6382, 2018 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30228030
10.
Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen.
mBio
; 9(1)2018 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29487236
11.
Comparison of the immune response during acute and chronic Staphylococcus aureus infection.
PLoS One
; 13(3): e0195342, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29596507
12.
Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.
Vaccine
; 35(51): 7160-7165, 2017 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122386
13.
Type IV transporters of pathogenic bacteria.
Curr Opin Microbiol
; 6(1): 29-34, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12615216
14.
Mechanistic Analysis of the Effect of Deamidation on the Immunogenicity of Anthrax Protective Antigen.
Clin Vaccine Immunol
; 23(5): 396-402, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26912784
15.
RNA-Seq Analysis of the Host Response to Staphylococcus aureus Skin and Soft Tissue Infection in a Mouse Model.
PLoS One
; 10(4): e0124877, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25901897
16.
The case for developing consensus standards for research in microbial pathogenesis: Bacillus anthracis toxins as an example.
Infect Immun
; 77(10): 4182-6, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19651858
17.
Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections.
Clin Vaccine Immunol
; 21(5): 622-7, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24574539
18.
Immunogenicity analysis of Staphylococcus aureus clumping factor A genetic variants.
Clin Vaccine Immunol
; 20(8): 1338-40, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23803901
19.
Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
PLoS One
; 8(4): e63040, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23658662
20.
Licensure of vaccines using the Animal Rule.
Curr Opin Virol
; 2(3): 353-6, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22709520